The wholesale drugstore AD "Dr. Panovski" has been part of the family of 200 LARGEST AND SUCCESSFUL since the very beginning of the project, back in 2003.

As one of the key players in the Macedonian pharmaceutical and healthcare industry, the company has been bringing high-quality medicines and medical devices to our market for more than 30 years.

The company's success based on numbers and financial parameters

The success of a company can be discussed based on multiple parameters, but if you look at the numbers and the graph presented within the 200 LARGEST AND SUCCESSFUL project, it is notable that this company has been recording continuous growth in the period since it became part of this family.

As can be seen from the graph itself, for this company, 2023 will be a year that will be remembered for its greatest success in the last two decades.

It best shows that this is the year when the company achieved the greatest growth in revenue, but also in profit before tax.

Namely, if in 2003 , the company generated revenue of 657,246,993 denars , or about 10 million and 687 thousand euros, in 2023, that amount increased more than threefold (2,267,070,394 denars).

However, success and growth did not happen in a straight line.

The company has experienced both growth and decline over the years, but this has certainly been within the framework of profitability.

From 2018 onwards, a continuous increase in income can be observed, and the biggest rebound can be observed precisely in the period between 2022 and 2023.

In 2022, "Dr. Panovski" achieved revenue of 1,589,240,446 denars , and profit before tax of 139,500,145 denars .

Next year, 2023, revenue growth is 42.65% , while pre-tax profit growth is 31.14%.

If we calculate the growth of pre-tax profit over a period of 5 years , i.e. from 2018 to 2023, it can be concluded that it amounts to 124.67%.

According to these financial parameters, in 2023, AD "Dr. Panovski" is ranked 125th on the list of largest companies , and 105th on the list of most successful .

Thanks to the increased growth in revenue and profit before tax, the company managed to move up 61 places on the list of the largest companies, and 17 places on the ranking list of the largest companies, in just one year.

Innovation, following trends and collaborating with the best – the key to successful development

Here, of course, the question arises: what is the company's formula for success?

As a company whose primary goal is to meet the needs of patients through the marketing of various types of safe and quality medical products, AD "Dr. Panovski" is largely a positive example of business.

Choosing the right partnerships, as well as an innovative approach and following trends are key to the company's success.

The wide range of   The medical products that AD "Dr. Panovski" works with are due to many years of cooperation with a large number of world-renowned manufacturers from abroad.

AD "Dr. Panovski" collaborates with a large number of renowned names and giants in the global medical, pharmaceutical and biochemical industry, which push the boundaries and constantly record new achievements, thus contributing to the progress of medicine.

The company collaborates with Swiss giants Roche and Swixx, as well as other globally renowned companies such as Shire/Takeda, Zentiva, Terumo BCT, etc.

AD "Dr. Panovski" has been participating in public procurement tenders in the Macedonian healthcare sector for years, being one of the key players without whom Macedonian operating rooms could not function.

In the last few years, the company has also contributed to aesthetic medicine, through the import of aesthetic products, i.e. minimally invasive products, and when selecting collaborators in this area, it once again opted for the best.

Thanks to AD "Dr. Panovski", the non-invasive aesthetic medicine products of the company Croma-Pharma are available on the Macedonian market, which have managed to meet the high European criteria for quality and safety.

Namely, in 2023, Croma-Pharma's Saypha®RICH filler was the first product of its type to receive approval for use, after the EU introduced stricter rules for the use of these products through the Medical Devices Regulation (MDR).

Such approval is a guarantee of product quality, patient safety, and the effectiveness of treatments with them.

Thanks to the innovative approach, the selection of quality brands and the constant monitoring of trends, AD "Dr. Panovski" has been writing a success story in the Macedonian economy for decades.

This wholesaler is an example of how even with a small number of employees (around 60) real success can be achieved, if you have an idea and vision in which direction and how you should progress.